Bilaketaren emaitzak - Arlene A. Forastiere

Findu emaitzak
  1. 1
    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom?

    Controversies in Treatment Deintensification of Human Papillomavirus–Associated Oropharyngeal Carcinomas: Should We, How Should We, and for Whom? nork Harry Quon, Arlene A. Forastiere

    Argitaratua 2013
    Testu osoa Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck

    Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck nork Athanassios Argiris, Yi Li, Arlene A. Forastiere

    Argitaratua 2004
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes

    Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes nork Arlene A. Forastiere, Randal S. Weber, Andy Trotti

    Argitaratua 2015
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    HPV-associated head and neck cancer: a virus-related cancer epidemic

    HPV-associated head and neck cancer: a virus-related cancer epidemic nork Shanthi Marur, Gypsyamber D’Souza, William H. Westra, Arlene A. Forastiere

    Argitaratua 2010
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Head and Neck Cancer: Recent Advances and New Standards of Care

    Head and Neck Cancer: Recent Advances and New Standards of Care nork Arlene A. Forastiere, Andy Trotti, David G. Pfister, Jennifer R. Grandis

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy

    Outcome of Elderly Patients With Recurrent or Metastatic Head and Neck Cancer Treated With Cisplatin-Based Chemotherapy nork Athanassios Argiris, Yi Li, Barbara A. Murphy, Corey J. Langer, Arlene A. Forastiere

    Argitaratua 2004
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of the Eastern Cooperative Oncology Group (E2382)

    Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of... nork Harry Quon, Traci Leong, Robert E. Haselow, Bruce Leipzig, Jay S. Cooper, Arlene A. Forastiere

    Argitaratua 2010
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck

    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck nork Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, Rita Axelrod, Ronald C. DeConti, Arlene A. Forastiere

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region

    Genetic Alterations in Barrett Esophagus and Adenocarcinomas of the Esophagus and Esophagogastric Junction Region nork Tsung‐Teh Wu, Toshiaki Watanabe, Richard F. Heitmiller, Marianna Zahurak, Arlene A. Forastiere, Stanley R. Hamilton

    Argitaratua 1998
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma

    Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma nork Mark B. Orringer, Arlene A. Forastiere, Claudia Perez-Tamayo, Susan G. Urba, Bonnie J. Takasugi, Judith Bromberg

    Argitaratua 1990
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials

    Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials nork Athanassios Argiris, S. Li, Musie Ghebremichael, Ann Marie Egloff, Ling Wang, Arlene A. Forastiere, Barbara Burtness, Ranee Mehra

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

    Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis nork Mitchell Machtay, Jennifer Moughan, A. Trotti, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial

    Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial nork Athanassios Argiris, Musie Ghebremichael, Jill Gilbert, Ju-Whei Lee, Kamakshi Sachidanandam, Jill Kolesar, Barbara Burtness, Arlene A. Forastiere

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy

    Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy nork Antonio Jimeno, P. Kulesza, Jenna Wheelhouse, Andrew M. Chan, X Zhang, E Kincaid, Allen Chen, Douglas P. Clark, Arlene A. Forastiere, Manuel Hidalgo

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients

    Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients nork Amitabh Chak, Marcia I. Canto, Gregory S. Cooper, Gerard Isenberg, Joseph Willis, Nathan Levitan, Julie Clayman, Arlene A. Forastiere, Elisabeth I. Heath, Michael Sivak

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck

    Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck nork Joseph Brennan, Jay O. Boyle, Wayne M. Koch, Steven N. Goodman, Ralph H. Hruban, Yolanda Eby, Marion Couch, Arlene A. Forastiere, David Sidransky

    Argitaratua 1995
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)

    Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-... nork Adam S. Garden, Jonathan Harris, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber, K. Kian Ang

    Argitaratua 2008
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399

    Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology... nork Anthony J. Cmelak, Sigui Li, Meredith A. Goldwasser, Barbara A. Murphy, Michael W. Cannon, Harlan Pinto, David I. Rosenthal, Maura L. Gillison, Arlene A. Forastiere

    Argitaratua 2007
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis

    Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis nork Mitchell Machtay, Jennifer Moughan, Andrew Farach, Elizabeth Martin-O'Meara, James M. Galvin, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14

    Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14 nork K. Kian Ang, Jonathan Harris, Adam S. Garden, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: